In vitro activity of nemonoxacin, a novel nonfluorinated quinolone antibiotic, against Chlamydia trachomatis and Chlamydia pneumoniae. - Wikidata - awgldk - TriplyDB

In vitro activity of nemonoxacin, a novel nonfluorinated quinolone antibiotic, against Chlamydia trachomatis and Chlamydia pneumoniae.

In vitro activity of nemonoxacin, a novel nonfluorinated quinolone antibiotic, against Chlamydia trachomatis and Chlamydia pneumoniae.

http://www.wikidata.org/entity/Q37845251

about

Review of nemonoxacin with special focus on clinical development Antibiotics in the clinical pipeline at the end of 2015.Amphipathic β2,2-Amino Acid Derivatives Suppress Infectivity and Disrupt the Intracellular Replication Cycle of Chlamydia pneumoniae.Treatment of Chlamydial infections: 2014 update.The potential role of nemonoxacin for treatment of common infections.Renaissance of antibiotics against difficult infections: Focus on oritavancin and new ketolides and quinolones.Nemonoxacin: first global approval.Atypical Pneumonia: Updates on Legionella, Chlamydophila, and Mycoplasma Pneumonia.

P2860

Q26830778-2EEC6FF5-3BC7-4CD3-999A-6CE54ECF40DD Q30249262-87596DA8-11D3-4409-BD7D-91D3690D3B3E Q36046741-020C62A1-F134-4630-A72B-58B6578C4544 Q37842306-56C69BBA-CB73-4D22-8051-003A198241AB Q37842543-AD5FD96F-F0A8-4E17-8446-A1A5905BDDAD Q38233471-2E28B0F1-CF97-4932-85F7-A404194A4A3C Q38235601-CF7EE21A-33B4-4CB8-B332-66F8B280116D Q39118434-C7CC80F7-4BFB-4829-9164-D9814EA6EF6B

P2860

In vitro activity of nemonoxacin, a novel nonfluorinated quinolone antibiotic, against Chlamydia trachomatis and Chlamydia pneumoniae.

http://www.wikidata.org/entity/Q37845251

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 23 December 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

In vitro activity of nemonoxac ...... atis and Chlamydia pneumoniae.

@en

In vitro activity of nemonoxac ...... atis and Chlamydia pneumoniae.

@nl

type

label

In vitro activity of nemonoxac ...... atis and Chlamydia pneumoniae.

@en

In vitro activity of nemonoxac ...... atis and Chlamydia pneumoniae.

@nl

prefLabel

In vitro activity of nemonoxac ...... atis and Chlamydia pneumoniae.

@en

In vitro activity of nemonoxac ...... atis and Chlamydia pneumoniae.

@nl

P1433

Q37845251-1970866A-8D8D-4133-85FE-18BE1854FF04

P1476

Q37845251-FBF8035E-548A-42CD-B3FD-6DE051FA8D74

P2093

Q37845251-51ADE92D-514C-4CD0-90AA-673EE712AFA1

Q37845251-5840D2FC-7110-4C44-9865-B7AC2E3EC296

Q37845251-CB643E36-FB33-4081-A478-EC869068EFF3

P2860

Q37845251-01CD7FD1-AF1F-4E25-A18E-52BEA11962F9

Q37845251-087397D7-18A0-4BE4-AE77-BE0C3A6B48C4

Q37845251-2A8F8AD0-1A34-4E43-BE24-8D4D91DF72D5

Q37845251-35901851-1023-43F6-A61F-EB6324AD7B4F

Q37845251-6D1BD2BA-B215-46E1-8A09-01CDB05E6FD3

Q37845251-750008FD-645F-409B-B63F-736D6DABD84D

Q37845251-7F91F787-4BA7-45FD-83C7-E921DD2F0835

Q37845251-A77B8ABF-B9B8-4C87-B903-9C24394EDBFD

Q37845251-B6059BE5-4726-4B6B-A9E3-B2F293DC9C40

Q37845251-B836A1F2-1177-4843-AF2C-5DE4CA093AEF

P304

Q37845251-E557CB2A-5749-44D5-8450-E4EAE3E680C5

P31

Q37845251-1B2CF417-DD42-4AF0-B0A6-71101DA75CA2

P356

Q37845251-8F539523-A8BB-4A39-BD45-2D16503AC3AD

P407

Q37845251-E2755617-1247-4AFF-9CD8-72E4B378D282

P433

Q37845251-A4B390B6-F551-47E8-90F3-A8C3C6C4C589

P478

Q37845251-0119717B-3348-4348-82AD-8A2201607C94

P577

Q37845251-533EDDDD-5F77-4CB4-95D6-3F4E58CCFE8B

P698

Q37845251-B66E9089-B426-43E6-B5E4-C21B3EF411A6

P921

Q37845251-1F821A66-E93F-4BDF-99C4-40CB27AE0FDE

Q37845251-5B5750B8-F73B-40D1-920B-D65C569E8E11

P932

Q37845251-3AAA7756-E90D-452F-8730-C673CD5E1233

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

In vitro activity of nemonoxac ...... atis and Chlamydia pneumoniae.

@en

P2093

Kobkul Chotikanatis

http://www.w3.org/2001/XMLSchema#string

Margaret R Hammerschlag

http://www.w3.org/2001/XMLSchema#string

Stephan A Kohlhoff

http://www.w3.org/2001/XMLSchema#string

P2860

Multiple-dose safety, tolerability, and pharmacokinetics of oral nemonoxacin (TG-873870) in healthy volunteers.

Comparative in vitro activities of nemonoxacin (TG-873870), a novel nonfluorinated quinolone, and other quinolones against clinical isolates

Efficacy and safety of nemonoxacin versus levofloxacin for community-acquired pneumonia

Safety and clinical pharmacokinetics of nemonoxacin, a novel non-fluorinated quinolone, in healthy Chinese volunteers following single and multiple oral doses.

Multicenter study in Taiwan of the in vitro activities of nemonoxacin, tigecycline, doripenem, and other antimicrobial agents against clinical isolates of various Nocardia species

In vitro activity of nemonoxacin, a novel nonfluorinated quinolone, against 2,440 clinical isolates.

Use of HEp-2 cells for improved isolation and passage of Chlamydia pneumoniae.

Involvement of topoisomerase IV and DNA gyrase as ciprofloxacin targets in Streptococcus pneumoniae.

In vitro activity of nemonoxacin, tigecycline, and other antimicrobial agents against Helicobacter pylori isolates in Taiwan, 1998-2007.

In vitro activity of nemonoxacin (TG-873870), a novel non-fluorinated quinolone, against clinical isolates of Staphylococcus aureus, enterococci and Streptococcus pneumoniae with various resistance phenotypes in Taiwan.

P304

1800-1801

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.02263-13

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

58

http://www.w3.org/2001/XMLSchema#string

P577

2013-12-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24366753

http://www.w3.org/2001/XMLSchema#string

P921

Chlamydia trachomatis

P932

3957896

http://www.w3.org/2001/XMLSchema#string